• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化慢性感染患者体内 HBV 特异性 T 细胞体外扩增的培养条件。

Optimization of culture conditions for HBV-specific T cell expansion in vitro from chronically infected patients.

机构信息

Department of Laboratory Medicine, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

Department of Laboratory Medicine, Guizhou Provincial People's Hospital, Guiyang, China.

出版信息

BMC Biotechnol. 2024 Oct 14;24(1):80. doi: 10.1186/s12896-024-00908-8.

DOI:10.1186/s12896-024-00908-8
PMID:39402512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11476462/
Abstract

BACKGROUND

Hepatitis B virus (HBV) clearance depends on an effective adaptive immune response, especially HBV-specific T cell-mediated cellular immunity; however, it is difficult to produce enough HBV-specific T cells effectively.

RESULTS

In this work, we investigated the proportions of stimulated cells, serum, and culture media as the three primary factors to determine the most effective procedure and applied it to HLA-A2 (+) people. In parallel, we also examined the correlation between clinical parameters and HBV-specific immunity. Concerning amplification efficiency, 4 × 10 cells stimulation was superior to 2 × 10 cells stimulation, AIM-V medium outperformed 1640 medium, and fetal bovine serum (FBS) exceeded human AB serum under comparable conditions. As expected, this procedure is also suitable for developing HBV-specific CD8 + T cells in HLA-A2(+) individuals. Expanded HBV-specific T cell responses decreased with treatment time and were negatively correlated with HBV DNA and HBsAg. Furthermore, the number of HBV-specific IFN-γ + SFCs was strongly correlated with the ALT level and negatively correlated with the absolute lymphocyte count and the ALB concentration.

CONCLUSIONS

We confirm that stimulating 4 × 10 PBMCs in AIM-V medium supplemented with 10% FBS is the best approach and that HBeAg, HBsAg, and ALB are independent predictors of HBV-specific T-cell responses.

摘要

背景

乙型肝炎病毒 (HBV) 的清除依赖于有效的适应性免疫反应,尤其是 HBV 特异性 T 细胞介导的细胞免疫;然而,很难有效地产生足够的 HBV 特异性 T 细胞。

结果

在这项工作中,我们研究了刺激细胞、血清和培养基的比例作为三个主要因素,以确定最有效的程序,并将其应用于 HLA-A2(+)人群。同时,我们还检查了临床参数与 HBV 特异性免疫之间的相关性。关于扩增效率,4×10 个细胞刺激优于 2×10 个细胞刺激,AIM-V 培养基优于 1640 培养基,在可比条件下,胎牛血清 (FBS) 优于人 AB 血清。不出所料,该程序也适用于在 HLA-A2(+)个体中开发 HBV 特异性 CD8+T 细胞。扩增的 HBV 特异性 T 细胞反应随治疗时间而降低,与 HBV DNA 和 HBsAg 呈负相关。此外,HBV 特异性 IFN-γ+SFC 的数量与 ALT 水平呈强烈相关,与绝对淋巴细胞计数和 ALB 浓度呈负相关。

结论

我们证实,在补充有 10%FBS 的 AIM-V 培养基中刺激 4×10 PBMC 是最佳方法,HBeAg、HBsAg 和 ALB 是 HBV 特异性 T 细胞反应的独立预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/49e40d77136e/12896_2024_908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/7a7267a25799/12896_2024_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/9bb00a26e365/12896_2024_908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/1b3fc2868e9a/12896_2024_908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/49e40d77136e/12896_2024_908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/7a7267a25799/12896_2024_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/9bb00a26e365/12896_2024_908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/1b3fc2868e9a/12896_2024_908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e996/11476462/49e40d77136e/12896_2024_908_Fig4_HTML.jpg

相似文献

1
Optimization of culture conditions for HBV-specific T cell expansion in vitro from chronically infected patients.优化慢性感染患者体内 HBV 特异性 T 细胞体外扩增的培养条件。
BMC Biotechnol. 2024 Oct 14;24(1):80. doi: 10.1186/s12896-024-00908-8.
2
Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.乙肝病毒(HBV)表面抗原(HBsAg)清除后数十年,针对 HBV 核心的 CD8+ T 细胞应答几乎检测不到。
J Hepatol. 2015 Jul;63(1):13-9. doi: 10.1016/j.jhep.2015.01.030. Epub 2015 Jan 31.
3
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.乙型肝炎表面抗原对慢性乙型肝炎病毒感染患者病毒特异性和整体 T 细胞的影响。
Gastroenterology. 2020 Aug;159(2):652-664. doi: 10.1053/j.gastro.2020.04.019. Epub 2020 Apr 14.
4
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.细胞介导的免疫反应特征可识别隐匿性乙型肝炎病毒感染的不同模式。
Gastroenterology. 2008 May;134(5):1470-81. doi: 10.1053/j.gastro.2008.02.017. Epub 2008 Feb 14.
5
TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.HBV 特异性 CD4 T 细胞的 TNF-α/IFN-γ 谱与慢性 HBV 感染中的肝损伤和病毒清除相关。
J Hepatol. 2020 Jan;72(1):45-56. doi: 10.1016/j.jhep.2019.08.024. Epub 2019 Sep 6.
6
[Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].[采用四聚体HLA-A2/核心18-27复合物直接分析慢性乙型肝炎中HBV特异性CD8 +淋巴细胞]
Taehan Kan Hakhoe Chi. 2002 Jun;8(2):139-48.
7
Study on the distribution of CD8+ memory T cell subsets and IFN-γ level during the spontaneous clearance of hepatitis B virus in patients with chronic hepatitis B virus infection.研究慢性乙型肝炎病毒感染者体内乙型肝炎病毒自发清除过程中 CD8+记忆 T 细胞亚群分布及 IFN-γ水平的变化。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4675-4679.
8
Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.来自乙肝相关肝细胞癌患者的乙肝病毒(HBV)抗原脉冲单核细胞衍生树突状细胞在体外能显著增强特异性T细胞反应。
Clin Exp Immunol. 2007 Feb;147(2):277-86. doi: 10.1111/j.1365-2249.2006.03281.x.
9
Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells.免疫动员单克隆 T 细胞受体介导乙型肝炎感染细胞的特异性和快速清除。
Hepatology. 2020 Nov;72(5):1528-1540. doi: 10.1002/hep.31503.
10
Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.通过慢性和已治愈乙肝患者的γ干扰素反应评估代表乙肝核心抗原和表面抗原表位的20种肽的免疫原性
BMC Immunol. 2015 Nov 2;16:65. doi: 10.1186/s12865-015-0127-7.

本文引用的文献

1
Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B.代谢干预可改善慢性乙型肝炎患者乙肝包膜特异性 T 细胞应答。
Hepatol Int. 2023 Oct;17(5):1125-1138. doi: 10.1007/s12072-023-10490-4. Epub 2023 Mar 28.
2
HBV Core-specific CD4 T cells correlate with sustained viral control upon off-treatment in HBeAg-positive chronic hepatitis B patients.HBV 核心特异性 CD4 T 细胞与 HBeAg 阳性慢性乙型肝炎患者停药后持续病毒控制相关。
Antiviral Res. 2023 May;213:105585. doi: 10.1016/j.antiviral.2023.105585. Epub 2023 Mar 23.
3
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
肝细胞内通路失调定义了慢性乙型肝炎中乙型肝炎病毒特异性 CD8 T 细胞重建的新的分子靶点。
J Hepatol. 2023 Jul;79(1):50-60. doi: 10.1016/j.jhep.2023.02.035. Epub 2023 Mar 7.
4
Hepatitis B functional cure and immune response.乙型肝炎的功能性治愈和免疫反应。
Front Immunol. 2022 Nov 17;13:1075916. doi: 10.3389/fimmu.2022.1075916. eCollection 2022.
5
Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家乙型肝炎负担,1990-2019 年:基于 2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):796-829. doi: 10.1016/S2468-1253(22)00124-8. Epub 2022 Jun 21.
6
How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?如何实现乙肝功能性治愈:停止核苷(酸)类似物,加用干扰素或开发新药?
J Hepatol. 2022 Jun;76(6):1249-1262. doi: 10.1016/j.jhep.2021.11.024.
7
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B.体外多酚处理慢性乙型肝炎中乙型肝炎病毒特异性 CD8 T 细胞的功能重建。
J Hepatol. 2021 Apr;74(4):783-793. doi: 10.1016/j.jhep.2020.10.034. Epub 2020 Nov 11.
8
Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay.采用细胞酶联免疫斑点试验鉴定慢性乙型肝炎病毒感染患者 HBcAg 特异性 T 细胞与病毒控制之间的关系。
J Leukoc Biol. 2021 Feb;109(2):455-465. doi: 10.1002/JLB.5MA0620-023RR. Epub 2020 Jul 3.
9
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.乙型肝炎表面抗原对慢性乙型肝炎病毒感染患者病毒特异性和整体 T 细胞的影响。
Gastroenterology. 2020 Aug;159(2):652-664. doi: 10.1053/j.gastro.2020.04.019. Epub 2020 Apr 14.
10
Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype.人血小板裂解物培养基补充剂支持慢病毒转导和扩增人 T 淋巴细胞,同时保持记忆表型。
J Immunol Res. 2019 Sep 4;2019:3616120. doi: 10.1155/2019/3616120. eCollection 2019.